Hot Pursuit     13-Mar-25
J B Chemicals & Pharmaceuticals Ltd Slides 3.64%
J B Chemicals & Pharmaceuticals Ltd has lost 10.02% over last one month compared to 4.3% fall in BSE Healthcare index and 2.82% drop in the SENSEX

J B Chemicals & Pharmaceuticals Ltd fell 3.64% today to trade at Rs 1450. The BSE Healthcare index is down 0.33% to quote at 39246.76. The index is down 4.3 % over last one month. Among the other constituents of the index, Orchid Pharma Ltd decreased 2.55% and Jupiter Life Line Hospitals Ltd lost 1.43% on the day. The BSE Healthcare index went up 16.34 % over last one year compared to the 1.9% surge in benchmark SENSEX.

J B Chemicals & Pharmaceuticals Ltd has lost 10.02% over last one month compared to 4.3% fall in BSE Healthcare index and 2.82% drop in the SENSEX. On the BSE, 724 shares were traded in the counter so far compared with average daily volumes of 3369 shares in the past one month. The stock hit a record high of Rs 2029 on 16 Aug 2024. The stock hit a 52-week low of Rs 1448.6 on 13 Mar 2025.

Previous News
  J B Chemicals & Pharmaceuticals schedules board meeting
 ( Corporate News - 22-Apr-25   17:20 )
  JB Chemicals & Pharma receives USFDA approval for Bisoprolol Tablets
 ( Hot Pursuit - 21-Apr-25   09:57 )
  J B Chemicals & Pharmaceuticals receives USFDA approval for Bisoprolol Tablets
 ( Corporate News - 18-Apr-25   15:06 )
  Capri Global Capital Ltd leads losers in 'A' group
 ( Hot Pursuit - 27-Mar-25   15:00 )
  Volumes jump at J B Chemicals & Pharmaceuticals Ltd counter
 ( Hot Pursuit - 27-Mar-25   14:30 )
  Volumes spurt at Galaxy Surfactants Ltd counter
 ( Hot Pursuit - 27-Mar-25   11:00 )
  J B Chemicals & Pharmaceuticals allots 1,700 equity shares under ESOS
 ( Corporate News - 18-Mar-25   19:15 )
  JB Chemicals Panoli facility clears USFDA inspection with zero observations
 ( Hot Pursuit - 15-Mar-25   11:58 )
  J B Chemicals & Pharmaceuticals Ltd Slides 3.64%
 ( Hot Pursuit - 13-Mar-25   09:30 )
  JB Chemicals rises after Panoli facility completes US FDA audit with no observations
 ( Hot Pursuit - 10-Mar-25   11:00 )
  Orchid Pharma continues to be under rating watch with developing implications
 ( Corporate News - 07-Mar-25   13:33 )
Other Stories
  Refex Inds Q4 PAT climbs 41% YoY to Rs 48 cr
  24-Apr-25   14:46
  Taylormade Renewables Ltd leads losers in 'B' group
  24-Apr-25   14:45
  Volumes spurt at Syngene International Ltd counter
  24-Apr-25   14:30
  Elecon Engineering soars after Q4 PAT rises 41% YoY; EBITDA at Rs 195 crore
  24-Apr-25   14:25
  Servotech Renewable gains on securing 4.1 MW rooftop solar order from East Coast Railway
  24-Apr-25   14:21
  Adani Green Energy rises after arm signs PPA for 1,250 MW energy storage project
  24-Apr-25   14:11
  Real Estate stocks slide
  24-Apr-25   14:00
  Black Box hits the roof after bagging orders worth Rs Rs 1,550 crore in Q4
  24-Apr-25   13:51
  Divis Lab spurts as broker maintains buy call
  24-Apr-25   13:45
  Astec Life tumbles after Q4 net loss widens to Rs 16 cr
  24-Apr-25   13:24
Back Top